Global leader in medical technology, Medtronic, has been granted CE Mark approval for its radial artery access portfolio, comprising of their Rist 079 Radial Access Guide Catheter and Rist Radial Access Selective Catheter. Characterized by its ability to access the neuro vasculature via the radial artery versus access through the transfemoral artery, the Rist 079 Radial Access Guide Catheter has already received 501(K) clearance by the US FDA (Food and Drug Administration), receiving strong customer feedback in over 100 cases. In 2018, The American Heart Association advised a radial-first approach for acute coronary syndrome, ensuring that transracial techniques are incorporated in the standards of care within the cardiac interventional community.

Read more here.

More on: